检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Alessandra Tedeschi,Richard Greil,Fatih Demirkan,Tadeusz Robak,Carol Moreno,Paul M Barr,Bertrand Anz,David Simpson,Gianluca Gaidano,Osnat Bairey,Don Stevens,Devinder Gill,Ian W Flinn,Thomas J Kipps,Jan A Burger,Jennifer Lin,Thomas Webb, Viktor Fedorov,Lori Styles,John G Gribben

HAEMATOLOGICA（2020）

引用 8|浏览54
暂无评分
关键词
Chemoimmunotherapy,Chronic Lymphocytic Leukemia,Cross-trial analysis,Ibrutinib,Obinutuzumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要